Cargando…
Considering Intrauterine Location in a Model of Fetal Growth Restriction After Maternal Titanium Dioxide Nanoparticle Inhalation
Fetal growth restriction (FGR) is a condition with several underlying etiologies including gestational disease (e.g., preeclampsia, gestational diabetes) and xenobiotic exposure (e.g., environmental contaminants, pharmaceuticals, recreational drugs). Rodent models allow study of FGR pathogenesis. Ho...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121264/ https://www.ncbi.nlm.nih.gov/pubmed/33997857 http://dx.doi.org/10.3389/ftox.2021.643804 |
_version_ | 1783692296630304768 |
---|---|
author | D'Errico, J. N. Fournier, S. B. Stapleton, P. A. |
author_facet | D'Errico, J. N. Fournier, S. B. Stapleton, P. A. |
author_sort | D'Errico, J. N. |
collection | PubMed |
description | Fetal growth restriction (FGR) is a condition with several underlying etiologies including gestational disease (e.g., preeclampsia, gestational diabetes) and xenobiotic exposure (e.g., environmental contaminants, pharmaceuticals, recreational drugs). Rodent models allow study of FGR pathogenesis. However, given the multiparous rodent pregnancy, fetal growth variability within uterine horns may arise. To ascertain whether intrauterine position is a determinant of fetal growth, we redesigned fetal weight analysis to include litter size and maternal weight. Our FGR model is produced by exposing pregnant Sprague Dawley rats to aerosolized titanium dioxide nanoparticles at 9.44 ± 0.26 mg/m(3) on gestational day (GD) 4, GD 12 or GD 17 or 9.53 ± 1.01 mg/m(3) between GD 4-GD 19. In this study fetal weight data was reorganized by intrauterine location (i.e., right/left uterine horn and ovarian/middle/vaginal position) and normalized by maternal weight and number of feti per uterine horn. A significant difference in fetal weight in the middle location in controls (0.061 g ± 0.001 vs. 0.055 g ± 0.002), GD 4 (0.033 g ± 0.003 vs. 0.049 g ± 0.004), and GD 17 (0.047 g ± 0.002 vs. 0.038 g ± 0.002) exposed animals was identified. Additionally, GD 4 exposure produced significantly smaller feti in the right uterine horn at the ovarian end (0.052 g ± 0.003 vs. 0.029 g ± 0.003) and middle of the right uterine horn (0.060 g ± 0.001 vs. 0.033 g ± 0.003). GD 17 exposure produced significantly smaller feti in the left uterine horn middle location (0.055g ± 0.002 vs. 0.033 ± 0.002). Placental weights were unaffected, and placental efficiency was reduced in the right uterine horn middle location after GD 17 exposure (5.74 g ± 0.16 vs. 5.09 g ± 0.14). These findings identified: (1) differences in fetal weight of controls between the right and left horns in the middle position, and (2) differential effects of single whole-body pulmonary exposure to titanium dioxide nanoparticles on fetal weight by position and window of maternal exposure. In conclusion, these results indicate that consideration for intrauterine position, maternal weight, and number of feti per horn provides a more sensitive assessment of FGR from rodent reproductive and developmental studies. |
format | Online Article Text |
id | pubmed-8121264 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-81212642021-05-14 Considering Intrauterine Location in a Model of Fetal Growth Restriction After Maternal Titanium Dioxide Nanoparticle Inhalation D'Errico, J. N. Fournier, S. B. Stapleton, P. A. Front Toxicol Toxicology Fetal growth restriction (FGR) is a condition with several underlying etiologies including gestational disease (e.g., preeclampsia, gestational diabetes) and xenobiotic exposure (e.g., environmental contaminants, pharmaceuticals, recreational drugs). Rodent models allow study of FGR pathogenesis. However, given the multiparous rodent pregnancy, fetal growth variability within uterine horns may arise. To ascertain whether intrauterine position is a determinant of fetal growth, we redesigned fetal weight analysis to include litter size and maternal weight. Our FGR model is produced by exposing pregnant Sprague Dawley rats to aerosolized titanium dioxide nanoparticles at 9.44 ± 0.26 mg/m(3) on gestational day (GD) 4, GD 12 or GD 17 or 9.53 ± 1.01 mg/m(3) between GD 4-GD 19. In this study fetal weight data was reorganized by intrauterine location (i.e., right/left uterine horn and ovarian/middle/vaginal position) and normalized by maternal weight and number of feti per uterine horn. A significant difference in fetal weight in the middle location in controls (0.061 g ± 0.001 vs. 0.055 g ± 0.002), GD 4 (0.033 g ± 0.003 vs. 0.049 g ± 0.004), and GD 17 (0.047 g ± 0.002 vs. 0.038 g ± 0.002) exposed animals was identified. Additionally, GD 4 exposure produced significantly smaller feti in the right uterine horn at the ovarian end (0.052 g ± 0.003 vs. 0.029 g ± 0.003) and middle of the right uterine horn (0.060 g ± 0.001 vs. 0.033 g ± 0.003). GD 17 exposure produced significantly smaller feti in the left uterine horn middle location (0.055g ± 0.002 vs. 0.033 ± 0.002). Placental weights were unaffected, and placental efficiency was reduced in the right uterine horn middle location after GD 17 exposure (5.74 g ± 0.16 vs. 5.09 g ± 0.14). These findings identified: (1) differences in fetal weight of controls between the right and left horns in the middle position, and (2) differential effects of single whole-body pulmonary exposure to titanium dioxide nanoparticles on fetal weight by position and window of maternal exposure. In conclusion, these results indicate that consideration for intrauterine position, maternal weight, and number of feti per horn provides a more sensitive assessment of FGR from rodent reproductive and developmental studies. Frontiers Media S.A. 2021-03-23 /pmc/articles/PMC8121264/ /pubmed/33997857 http://dx.doi.org/10.3389/ftox.2021.643804 Text en Copyright © 2021 D'Errico, Fournier and Stapleton. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Toxicology D'Errico, J. N. Fournier, S. B. Stapleton, P. A. Considering Intrauterine Location in a Model of Fetal Growth Restriction After Maternal Titanium Dioxide Nanoparticle Inhalation |
title | Considering Intrauterine Location in a Model of Fetal Growth Restriction After Maternal Titanium Dioxide Nanoparticle Inhalation |
title_full | Considering Intrauterine Location in a Model of Fetal Growth Restriction After Maternal Titanium Dioxide Nanoparticle Inhalation |
title_fullStr | Considering Intrauterine Location in a Model of Fetal Growth Restriction After Maternal Titanium Dioxide Nanoparticle Inhalation |
title_full_unstemmed | Considering Intrauterine Location in a Model of Fetal Growth Restriction After Maternal Titanium Dioxide Nanoparticle Inhalation |
title_short | Considering Intrauterine Location in a Model of Fetal Growth Restriction After Maternal Titanium Dioxide Nanoparticle Inhalation |
title_sort | considering intrauterine location in a model of fetal growth restriction after maternal titanium dioxide nanoparticle inhalation |
topic | Toxicology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121264/ https://www.ncbi.nlm.nih.gov/pubmed/33997857 http://dx.doi.org/10.3389/ftox.2021.643804 |
work_keys_str_mv | AT derricojn consideringintrauterinelocationinamodeloffetalgrowthrestrictionaftermaternaltitaniumdioxidenanoparticleinhalation AT fourniersb consideringintrauterinelocationinamodeloffetalgrowthrestrictionaftermaternaltitaniumdioxidenanoparticleinhalation AT stapletonpa consideringintrauterinelocationinamodeloffetalgrowthrestrictionaftermaternaltitaniumdioxidenanoparticleinhalation |